MedTrace Logo

Collection of Circulating Biomarkers in Pancreatic Cancer

NCT05743049 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-04-07

No results posted yet for this study

Summary

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Conditions

  • Pancreas Cancer

Interventions

OTHER

Obtaining blood for analysis of various circulating biomarkers

4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Mark O'Hara, MD · Abramson Cancer Center, University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2027-06-30
Completion
2028-01-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05743049 on ClinicalTrials.gov